Testing the performance of risk prediction models to determine progression to referable diabetic retinopathy in an Irish type 2 diabetes cohort

Smith, John J, Wright, David M, Stratton, Irene M, Scanlon, Peter H ORCID: 0000-0001-8513-710X and Lois, Noemi (2021) Testing the performance of risk prediction models to determine progression to referable diabetic retinopathy in an Irish type 2 diabetes cohort. British Journal of Ophthalmology. doi:10.1136/bjophthalmol-2020-318570 (In Press)

[img]
Preview
Text (Online first)
9618_Scanlon_et_al_(2021)_Testing_the_performance_of_risk_prediction.pdf - Published Version
Available under License Creative Commons Attribution 4.0.

Download (725kB) | Preview
[img]
Preview
Text (Article was peer reviewed - data was not peer reviewed - online first)
9618_Scanlon_et_al_(2021)_Article_plus_supplementary_data.pdf - Published Version
Available under License Creative Commons Attribution 4.0.

Download (930kB) | Preview

Abstract

Background /aims: To evaluate the performance of existing prediction models to determine risk of progression to referable diabetic retinopathy (RDR) using data from a prospective Irish cohort of people with type 2 diabetes (T2D). Methods: A cohort of 939 people with T2D followed prospectively was used to test the performance of risk prediction models developed in Gloucester, UK, and Iceland. Observed risk of progression to RDR in the Irish cohort was compared with that derived from each of the prediction models evaluated. Receiver operating characteristic curves assessed models' performance. Results: The cohort was followed for a total of 2929 person years during which 2906 screening episodes occurred. Among 939 individuals followed, there were 40 referrals (4%) for diabetic maculopathy, pre-proliferative DR and proliferative DR. The original Gloucester model, which includes results of two consecutive retinal screenings; a model incorporating, in addition, systemic biomarkers (HbA1c and serum cholesterol); and a model including results of one retinopathy screening, HbA1c, total cholesterol and duration of diabetes, had acceptable discriminatory power (area under the curve (AUC) of 0.69, 0.76 and 0.77, respectively). The Icelandic model, which combined retinopathy grading, duration and type of diabetes, HbA1c and systolic blood pressure, performed very similarly (AUC of 0.74). Conclusion: In an Irish cohort of people with T2D, the prediction models tested had an acceptable performance identifying those at risk of progression to RDR. These risk models would be useful in establishing more personalised screening intervals for people with T2D.

Item Type: Article
Article Type: Article
Uncontrolled Keywords: Eye (Globe); Imaging; Macula; Retina; Vision
Subjects: R Medicine > RA Public aspects of medicine > RA645.A-Z Individual diseases or groups of diseases, A-Z > RA645.D54 Diabetes
R Medicine > RE Ophthalmology
Depositing User: Susan Turner
Date Deposited: 29 Apr 2021 11:14
Last Modified: 29 Apr 2021 11:15
URI: http://eprints.glos.ac.uk/id/eprint/9618

University Staff: Request a correction | Repository Editors: Update this record

University Of Gloucestershire

Bookmark and Share

Find Us On Social Media:

Social Media Icons Facebook Twitter Google+ YouTube Pinterest Linkedin

Other University Web Sites

University of Gloucestershire, The Park, Cheltenham, Gloucestershire, GL50 2RH. Telephone +44 (0)844 8010001.